Mytreya Files New Patent for 'Anti-Aging' Composition
NQ Score
0/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Mytreya Co., Ltd. has filed a patent for an 'anti-aging composition' that uniquely combines NMN, exosomes, and allantoin. Developed in joint research with Miyazaki Prefecture and Tsutsumi Planning Co., Ltd., the composition utilizes the transdermal delivery technology 'nano PDS®' and has shown suppression of a senescence marker in tests.
AI Analysis
Frequently Asked Questions
- Q: What is the core technology of Mytreya's new patent?
- A: It is the unique combination of NMN, exosomes, and allantoin, delivered via the transdermal technology 'nano PDS®'.
- Q: When was this patent filed?
- A: May 14, 2026.
- Q: Who are the joint applicants for this patent?
- A: Mytreya Co., Ltd., Tsutsumi Planning Co., Ltd., and Miyazaki Prefecture.